Supira Medical announced today that it completed an oversubscribed Series E financing round, bringing in $120 million.

Dallas Mavericks star Kyrie Irving had surgery on the torn ACL in his left knee, starting a process of recovery that’s likely ...

Mummified flesh, preserved for centuries, seemed an obvious candidate for treating decay, wounds and internal deterioration.

Ochsner Health Medical Director for Cardiac Rehabilitation and Preventive Cardiology, Carl J. "Chip" Lavie, Jr., MD, recently co-authored a groundbreaking research study featured in the prestigious ...

Topline data were announced from pivotal phase 3 studies evaluating povorcitinib in adults with moderate to severe hidradenitis suppurativa.

The FDA has approved Tremfya as the “first and only” interleukin-23 inhibitor that offers both IV and fully subcutaneous ...

Experts discuss how cancer treatment and survivorship can be made more equitable and affordable through advocacy, outreach, and effective communication tools. Beyond Cancer: Caring for Young ...

Magen David Adom is Israel’s medical Iron Dome,” Dovrat Weizer, Chairwoman of Women of MDA, stated at The Jerusalem Post ...

Let’s dig into the relative performance of The Honest Company (NASDAQ:HNST) and its peers as we unravel the now-completed Q4 personal care earnings season. Wrapping up Q4 earnings, we look at ...

The FDA has approved guselkumab (Tremfya) as the first IL-23 inhibitor offering both subcutaneous and intravenous induction ...

A scientific technique that rapidly increases the body's production of anti-inflammatory cells promoted healing from heart attacks in mice, according to a new study by investigators from the Smidt ...

US-based Supira Medical has completed a $120m Series E funding round, with plans to use the capital to advance its position in the percutaneous ventricular assist device (pVAD) market. A portfolio ...